Search results
Results from the WOW.Com Content Network
AHFS/Drugs.com: International Drug Names: Routes of ... It was patented in 1981 and approved for medical use in 1991. [1] ... where it is sold as 4 mg tablets. References
Nifedipine was patented in 1967, and approved for use in the United States in 1981. [2] [6] [7] It is on the World Health Organization's List of Essential Medicines. [8] It is available as a generic medication. [2] In 2022, it was the 151st most commonly prescribed medication in the United States, with more than 3 million prescriptions. [9] [10]
Biperiden, sold under the brand name Akineton among others, is a medication used to treat Parkinson disease, certain drug-induced movement disorders [2] and Tourette Syndrome [citation needed]. It is not recommended for tardive dyskinesias. [3] It is taken by mouth, injection into a vein, or muscle. [2] [3]
Benzatropine , [2] known as benztropine in the United States and Japan, [3] is a medication used to treat movement disorders like parkinsonism and dystonia, as well as extrapyramidal side effects of antipsychotics, including akathisia. [4] It is not useful for tardive dyskinesia. [4] It is taken by mouth or by injection into a vein or muscle. [4]
Perindopril is a medication used to treat high blood pressure, heart failure, or stable coronary artery disease. [2] As a long-acting ACE inhibitor, it works by relaxing blood vessels and decreasing blood volume. As a prodrug, perindopril is hydrolyzed in the liver to its active metabolite, perindoprilat. It was patented in 1980 and approved ...
Ephenidine (also known as NEDPA and EPE) is a dissociative anesthetic that has been sold online as a designer drug. [1] [2] It is illegal in some countries as a structural isomer of the banned opioid drug lefetamine, but has been sold in countries where it is not yet banned. [3] [4]
Amisulpride is approved and used at low doses in the treatment of dysthymia and major depressive disorder. [10] [20] [11] [21] [22] [23] Whereas typical doses used in schizophrenia block postsynaptic dopamine D 2-like receptors and reduce dopaminergic neurotransmission, low doses of amisulpride preferentially block presynaptic dopamine D 2 and D 3 autoreceptors and thereby disinhibit dopamine ...
Like the other first-generation drugs of its class, it is considered a sedating antihistamine. [2] It was patented in 1948 and came into medical use in 1955. [3] In 2022, the combination with dextromethorphan and pseudoephedrine was the 265th most commonly prescribed medication in the United States, with more than 1 million prescriptions. [4] [5]